Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+2.21%
$88.27
100% positive prob.
5-Day Prediction
+3.70%
$89.55
100% positive prob.
20-Day Prediction
+2.18%
$88.24
95% positive prob.
SEC 8-K filings with transcript text
Feb 18, 2026 · 100% conf.
1D
+2.21%
$88.27
Act: -4.28%
5D
+3.70%
$89.55
Act: -9.51%
20D
+2.18%
$88.24
8-K
false 0001054905 0001054905 2026-02-17 2026-02-17
Washington, D.C. 20549 Form 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026
(Exact name of registrant as specified in its charter) Commission File Number: 1-13879
Delaware
98-0181725
(State or other jurisdiction of incorporation)
(IRS Employer Identification No.)
8310 South Valley Highway, Suite 350 Englewood, Colorado, 80112 (Address of principal executive offices, including zip code) (303)792-5554 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock
Item 2.02 Results of Operations and Financial Condition. On February 17, 2026, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2025 (the “Press Release”). Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
Number
Description
Method of Filing
99.1
Press Release dated February 17, 2026 announcing Innospec Inc.’s financial results for the fiscal year ended December 31, 2025.
Filed Herewith
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 18, 2026
By:
/s/ David B. Jones
David B. Jones
Senior Vice President, General Counsel and Chief Compliance Officer
Nov 5, 2025
8-K
false 0001054905 0001054905 2025-11-04 2025-11-04
Washington, D.C. 20549 Form 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2025
(Exact name of registrant as specified in its charter) Commission File Number: 1-13879
Delaware
98-0181725
(State or other jurisdiction of
(IRS Employer
incorporation)
Identification No.) 8310 South Valley Highway, Suite 350 Englewood, Colorado, 80112 (Address of principal executive offices, including zip code) (303)792-5554 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [ ] Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock
Item 2.02 Results of Operations and Financial Condition. On November 4, 2025, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025 (the “Press Release”). Item 7.01 Regulation FD Disclosure The Press Release also announced that on November 2, 2025, the Company’s Board of Directors declared a semi-annual dividend of $0.87 per share on the Company’s common stock (IOSP). The dividend will be paid on November 26, 2025, to holders of record on November 18, 2025. Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
Number
Description
Method of Filing
99.1
Press Release dated November 4, 2025, announcing Innospec Inc.’s financial results for the fiscal quarter ended September 30, 2025
Filed Herewith
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded
within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 5, 2025
By:
/s/ David B. Jones
David B. Jones
Senior Vice President, General Counsel and Chief Compliance Officer
Aug 6, 2025
8-K
false 0001054905 0001054905 2025-08-05 2025-08-05
Washington, D.C. 20549 Form 8-K
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025
(Exact name of registrant as specified in its charter) Commission File Number: 1-13879
Delaware
98-0181725
(State or other jurisdiction of
(IRS Employer
incorporation)
Identification No.) 8310 South Valley Highway, Suite 350 Englewood, Colorado, 80112 (Address of principal executive offices, including zip code) (303)792-5554 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [ ] Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common Stock
Item 2.02 Results of Operations and Financial Condition. On August 5, 2025, Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 30, 2025 (the “Press Release”). Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
Number
Description
Method of Filing
99.1
Press Release dated August 5, 2025 announcing Innospec Inc.’s financial results for the fiscal quarter ended June 30, 2025
Filed Herewith
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 6, 2025
By:
/s/ David B. Jones
David B. Jones
Senior Vice President, General Counsel and Chief Compliance Officer
This page provides Innospec Inc. (IOSP) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on IOSP's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.